131 related articles for article (PubMed ID: 35761463)
1. Effect of AR42 in Primary Vestibular Schwannoma Cells and a Xenograft Model of Vestibular Schwannoma.
Misztal C; Bracho O; Bas E; Estivill M; Ivan ME; Morcos J; Bhatia R; Telischi F; Liu XZ; Gultekin SH; Fernandez-Valle C; Dinh CT
Otol Neurotol; 2022 Jul; 43(6):694-701. PubMed ID: 35761463
[TBL] [Abstract][Full Text] [Related]
2. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
[TBL] [Abstract][Full Text] [Related]
3. A Xenograft Model of Vestibular Schwannoma and Hearing Loss.
Dinh CT; Bracho O; Mei C; Bas E; Fernandez-Valle C; Telischi F; Liu XZ
Otol Neurotol; 2018 Jun; 39(5):e362-e369. PubMed ID: 29557843
[TBL] [Abstract][Full Text] [Related]
4. Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.
Jacob A; Oblinger J; Bush ML; Brendel V; Santarelli G; Chaudhury AR; Kulp S; La Perle KM; Chen CS; Chang LS; Welling DB
Laryngoscope; 2012 Jan; 122(1):174-89. PubMed ID: 22109824
[TBL] [Abstract][Full Text] [Related]
5. CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.
Huegel J; Dinh CT; Martinelli M; Bracho O; Rosario R; Hardin H; Estivill M; Griswold A; Gultekin S; Liu XZ; Fernandez-Valle C
Oncotarget; 2022; 13():890-904. PubMed ID: 35875610
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.
Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS
Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162
[TBL] [Abstract][Full Text] [Related]
7. Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801.
Dougherty MC; Shibata SB; Clark JJ; Canady FJ; Yates CW; Hansen MR
J Neurosurg; 2023 Apr; 138(4):962-971. PubMed ID: 36087315
[TBL] [Abstract][Full Text] [Related]
8. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.
Booth L; Roberts JL; Sander C; Lee J; Kirkwood JM; Poklepovic A; Dent P
Oncotarget; 2017 Mar; 8(10):16367-16386. PubMed ID: 28146421
[TBL] [Abstract][Full Text] [Related]
9. Single Fraction and Hypofractionated Radiation Cause Cochlear Damage, Hearing Loss, and Reduced Viability of Merlin-Deficient Schwann Cells.
Dinh CT; Chen S; Nourbakhsh A; Padgett K; Johnson P; Goncalves S; Bracho O; Bas E; Bohorquez J; Monje PV; Fernandez-Valle C; Elsayyad N; Liu X; Welford SM; Telischi F
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345155
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein.
Perez ER; Bracho O; Ein L; Szczupak M; Monje PV; Fernandez-Valle C; Alshaiji A; Ivan M; Morcos J; Liu XZ; Hoffer M; Eshraghi A; Angeli S; Telischi F; Dinh CT
Otol Neurotol; 2018 Sep; 39(8):1053-1059. PubMed ID: 30001282
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent Detection of Vestibular Schwannoma Using Intravenous Sodium Fluorescein In Vivo.
Szczupak M; Peña SA; Bracho O; Mei C; Bas E; Fernandez-Valle C; Liu XZ; Telischi FF; Ivan M; Dinh CT
Otol Neurotol; 2021 Apr; 42(4):e503-e511. PubMed ID: 33492057
[TBL] [Abstract][Full Text] [Related]
12. Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.
Kersigo J; Gu L; Xu L; Pan N; Vijayakuma S; Jones T; Shibata SB; Fritzsch B; Hansen MR
Laryngoscope; 2021 Jan; 131(1):E259-E270. PubMed ID: 32438526
[TBL] [Abstract][Full Text] [Related]
13. Role of cervical vestibular evoked myogenic potentials (cVEMP) and auditory brainstem response (ABR) in the evaluation of vestibular schwannoma.
Valame DA; Gore GB
Braz J Otorhinolaryngol; 2017; 83(3):324-329. PubMed ID: 27174775
[TBL] [Abstract][Full Text] [Related]
14. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma.
Jacob A; Lee TX; Neff BA; Miller S; Welling B; Chang LS
Otol Neurotol; 2008 Jan; 29(1):58-68. PubMed ID: 18199958
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vestibular schwannoma cells with ErbB inhibitors.
Bush ML; Burns SS; Oblinger J; Davletova S; Chang LS; Welling DB; Jacob A
Otol Neurotol; 2012 Feb; 33(2):244-57. PubMed ID: 22222570
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.
Yang YL; Huang PH; Chiu HC; Kulp SK; Chen CS; Kuo CJ; Chen HD; Chen CS
Biochem Biophys Res Commun; 2013 May; 435(1):107-12. PubMed ID: 23624506
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry study of human vestibular nerve schwannoma differentiation.
Hung G; Colton J; Fisher L; Oppenheimer M; Faudoa R; Slattery W; Linthicum F
Glia; 2002 Jun; 38(4):363-70. PubMed ID: 12007148
[TBL] [Abstract][Full Text] [Related]
19. Lipid raft localization of ErbB2 in vestibular schwannoma and schwann cells.
Brown KD; Hansen MR
Otol Neurotol; 2008 Jan; 29(1):79-85. PubMed ID: 18199961
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue.
Taurone S; Bianchi E; Attanasio G; Di Gioia C; Ierinó R; Carubbi C; Galli D; Pastore FS; Giangaspero F; Filipo R; Zanza C; Artico M
Mol Med Rep; 2015 Jul; 12(1):737-45. PubMed ID: 25738867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
